FDA Hands Two API Makers 483s for Deficient Procedural Systems

Drug Industry Daily
A A
Two U.S. API makers are taking heat for a host of recordkeeping failures and related issues following FDA inspections of their production facilities.

To View This Article:

Login

Subscribe To Drug Industry Daily